Technology News
Technology stock news including AI, semiconductors, cloud computing, and software. Coverage of Big Tech earnings, product launches, and sector trends.
CoreWeave Gains as Nasdaq-100 Inclusion Nears, Backlog Optimism Grows
CoreWeave jumped 9.67% to $117.03 on Tuesday, buoyed by expectations of a backlog surpassing $131 billion and its upcoming Nasdaq-100 inclusion.
SpaceX Shares Rally on Record Options, Index Inclusion, and $60B Cursor Deal
SpaceX shares rallied 3.2% premarket following a record options session and a $60 billion all-stock acquisition of Anysphere, pushing its market cap above Amazon.
Archer Aviation's Cash Burn and FAA Progress Keep Shares in Check
Archer Aviation shares hover near $5.45 as the company enters Phase 4 of FAA certification for its Midnight eVTOL, while Q1 losses and cash burn remain key concerns.
Snap Shares Plunge After $2,195 AR Glasses Launch Sparks Investor Skepticism
Snap shares tumbled 9.63% to $5.16 after launching $2,195 Specs AR glasses, as investors question demand and profitability amid activist pressure.
Nvidia's $25B Bond Sale Triggers Stock Dip Amid AI Spending Concerns
Nvidia shares dropped 2.37% to $207.41 after the company upsized its first bond sale in five years to $25 billion, amid $85 billion in demand, shifting focus from AI growth to funding needs.
AST SpaceMobile Shares Dip After SpaceX Deploys Three New BlueBird Satellites
AST SpaceMobile shares dropped about 6% to $82.25 in premarket trading after SpaceX confirmed deployment of three new BlueBird satellites, a key step following April's loss of BlueBird 7.
Nokia Rises on AI Network Expansion Plans; Optical Demand in Focus
Nokia Oyj shares rose 1.17% to €12.15 in Helsinki after unveiling major AI-focused network expansions, including a U.S. photonic-chip packaging facility and a subsea cable upgrade in Southeast Asia.
UiPath Stock Slides Despite Maestro Case Launch Amid Tech Rout
UiPath shares dropped 2.7% to $10.52 after introducing Maestro Case, an AI-native case-management tool, as tech sector declines and market competition weighed on investor sentiment.
AtaiBeckley Surges as Phase 3 Trials for Depression Drug Begin
AtaiBeckley shares jumped 7.8% to $4.14 after announcing the start of Phase 3 trials for its lead depression drug BPL-003, with results expected in early 2029.
Roblox Shares Rally 8% on Global Safety Rollout and User Engagement Uptick
Roblox shares jumped 8% to $49.34 after launching global age-based accounts and a TD Cowen note highlighted a 10% weekend rise in concurrent users, as investors assess the impact of safety changes.